
Terlijet 1mg Injection
Marketer
Alniche Life Sciences Pvt Ltd
Salt Composition
Terlipressin (1mg)
Overview Terlijet 1mg Injection
Terlijet 1mg Injection treats severe bleeding from enlarged veins in the esophagus (the tube connecting your mouth and stomach), a condition known as esophageal varices. This medication constricts blood vessels, reducing blood flow to the affected area. Administration is strictly by a healthcare professional; self-injection is dangerous and prohibited. Dosage and frequency are determined solely by your physician, and treatment is reserved for life-threatening esophageal hemorrhage. Potential side effects include headache, bradycardia (slow heart rate), hypertension (high blood pressure), peripheral vasoconstriction, and peripheral ischemia or hypotension (low blood pressure). Report any persistent or worsening side effects to your doctor. Prior to treatment, disclose any pre-existing heart, liver, or kidney conditions, as well as all other medications you are currently using. This injection is unsuitable for pediatric patients.
Primary Ingredients of Terlijet 1mg Injection
No text was provided to rewrite. Please provide the text you wish to have rephrased.
Uses of Terlijet 1mg Injection
Life-threatening esophageal vein hemorrhage
Major Benefits of Terlijet 1mg Injection:
This medication will be administered by your physician or their registered nurse; self-medication is strictly prohibited.
Common Side effects of Terlijet 1mg Injection:
- Headache
- Slow heart rate
- Abdominal cramp
- Diarrhea
- High blood pressure
- Peripheral ischemia
- Vasoconstriction of the extremities
How to use Terlijet 1mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Terlijet 1mg Injection works:
Terlijet 1mg Injection constricts blood vessel walls, reducing blood flow to affected veins, thereby controlling or arresting hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Terlijet 1mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyUNSAFE
Administering Terlijet 1mg Injection to pregnant individuals poses a substantial risk. Pregnant women should consult their physician before use, as research in both animals and humans indicates considerable harm to the fetus.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Terlijet 1mg Injection with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Terlijet 1mg Injection on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data on Terlijet 1mg Injection use in individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data regarding Terlijet 1mg Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Terlijet 1mg Injection :
Omit any missed Terlijet 1mg Injection and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Terlijet 1mg Injection
| Label | Value |
|---|---|
| Chemical Category | Synthetic vasopressin |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
| Actions | Synthetic vasopressin |
